|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| Assets | ||||
| Current Assets: | ||||
| Due from Sponsor | ||||
| Cash | ||||
| Prepaid expenses | ||||
| Total Current Assets | ||||
| Non-current Assets: | ||||
| Cash and investments held in Trust Account | ||||
| Total Non-current Assets | ||||
| TOTAL ASSETS | ||||
| LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT | ||||
| Current liabilities: | ||||
| Accounts payable | ||||
| Over-allotment liability | ||||
| Accrued expenses | ||||
| Accrued offering costs | ||||
| Promissory notes | ||||
| Total Current Liabilities | ||||
| Deferred underwriting fee payable | ||||
| Non-current Liabilities: | ||||
| Deferred underwriting fee payable | ||||
| Total Non-current Liabilities | ||||
| TOTAL LIABILITIES | ||||
| Ordinary shares subject to possible redemption, 50,000,000 shares at redemption value of $10.28 and $10.10 per share as of June 30, 2026 and December 31, 2025, respectively | ||||
| Shareholders’ Deficit | ||||
| Ordinary shares, $0.0001 par value; 220,000,000 shares authorized; 13,700,000 shares issued and outstanding, excluding 50,000,000 shares subject to redemption as of June 30, 2026 and December 31, 2025 | ||||
| Accumulated deficit | ||||
| Total Shareholders’ Deficit | ||||
| TOTAL LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT |
Loading...
